Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05848297 · ClinicalTrials.gov registry record

Automated Robotic TCD in Traumatic Brain Injury

A clinical trial of Brain Injuries, Traumatic, sponsored by Virginia Commonwealth University.

Recruiting
Registry status
30
Enrollment target
3
Study locations

NCT05848297 is a study of Brain Injuries, Traumatic that is actively recruiting participants, run by Virginia Commonwealth University. The registered enrollment target is 30 participants, below the 255-participant average among 21 other Brain Injuries, Traumatic trials with a reported enrollment target (88% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05848297, a study of Brain Injuries, Traumatic, is actively recruiting participants, sponsored by Virginia Commonwealth University.

RECRUITING
Registry status
30 participants
Enrollment target
3
Study locations

Study Summary

This study's objective is to determine the safety, feasibility and efficacy of prolonged automated robotic TCD monitoring in critically ill patients with severe TBI across multiple clinical sites with varying levels of TCD availability and experience

Conditions Studied

Interventions

  • DEVICE Transcranial Doppler ultrasonography (TCD)

Study Locations (3)

California

  • University of California, Davis - Davis

North Carolina

  • Wake Forest University - Winston-Salem

Virginia

  • Virginia Commonwealth University - Richmond

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-05-20
Est. Completion 2026-05

Sponsor

Virginia Commonwealth University

558 total trials

What the Registry Record Tells You About NCT05848297

The ClinicalTrials.gov registry entry for NCT05848297 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 255-participant average among 21 other Brain Injuries, Traumatic trials with a reported enrollment target (88% lower). The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Brain Injuries, Traumatic appearing as the primary indexed condition, and to 1 intervention - of which Transcranial Doppler ultrasonography (TCD) is the first listed.

NCT05848297 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, North Carolina, Virginia.

Frequently Asked Questions

What is clinical trial NCT05848297 about?

NCT05848297 is a clinical study titled "Automated Robotic TCD in Traumatic Brain Injury". This study's objective is to determine the safety, feasibility and efficacy of prolonged automated robotic TCD monitoring in critically ill patients with severe TBI across multiple clinical sites with varying levels of TCD availability and experience

What is the current status of trial NCT05848297?

This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2025-05-20. Estimated completion is 2026-05.

What conditions does trial NCT05848297 study?

This clinical trial studies the following conditions: Brain Injuries, Traumatic.

What interventions are being tested in trial NCT05848297?

The interventions under investigation include: Transcranial Doppler ultrasonography (TCD) (DEVICE).

Who is sponsoring clinical trial NCT05848297?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05848297 being conducted?

This trial has 3 study locations across California, North Carolina, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Brain Injuries, Traumatic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.